3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 23 0 0 0 0 0 0 0999 V2000
1.4500 0.8927 0.2705 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8322 1.3687 0.0228 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0601 -0.8983 0.1699 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4020 -0.4428 -0.0861 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1267 1.7831 -0.2255 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6178 -2.6479 0.0597 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6073 0.0262 0.4223 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2926 -0.5907 -0.7650 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9835 0.4815 0.0247 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1214 0.4319 0.1494 C 1 0 0 0 0 0 0 0 0 0 0 0
-2.0690 0.8581 -0.0902 C 1 0 0 0 0 0 0 0 0 0 0 0
-1.3469 -1.2623 0.0475 C 1 0 0 0 0 0 0 0 0 0 0 0
2.5511 -0.5725 1.3265 H 0 0 0 0 0 0 0 0 0 0 0 0
2.9368 -0.3357 -1.7556 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6557 -1.6061 -0.6652 H 0 0 0 0 0 0 0 0 0 0 0 0
4.8140 0.1883 0.6549 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0913 1.4553 -0.4368 H 0 0 0 0 0 0 0 0 0 0 0 0
1.5543 1.9017 0.2577 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.0749 1.4446 -0.3131 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9234 2.7730 -0.2333 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.5720 -2.9687 -0.0299 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8543 -3.3027 0.1578 H 0 0 0 0 0 0 0 0 0 0 0 0
1 7 1 0 0 0 0
1 10 1 0 0 0 0
1 18 1 0 0 0 0
2 10 2 0 0 0 0
2 11 1 0 0 0 0
3 10 1 0 0 0 0
3 12 2 0 0 0 0
4 11 2 0 0 0 0
4 12 1 0 0 0 0
5 11 1 0 0 0 0
5 19 1 0 0 0 0
5 20 1 0 0 0 0
6 12 1 0 0 0 0
6 21 1 0 0 0 0
6 22 1 0 0 0 0
7 8 1 0 0 0 0
7 9 1 0 0 0 0
7 13 1 0 0 0 0
8 9 1 0 0 0 0
8 14 1 0 0 0 0
8 15 1 0 0 0 0
9 16 1 0 0 0 0
9 17 1 0 0 0 0
M ISO 3 10 13 11 13 12 13
4. 国际命名与标识
4.1 IUPAC Name
2-N-cyclopropyl-(2,4,6-13C3)1,3,5-triazine-2,4,6-triamine
4.2 InChl
InChI=1S/C6H10N6/c7-4-10-5(8)12-6(11-4)9-3-1-2-3/h3H,1-2H2,(H5,7,8,9,10,11,12)/i4+1,5+1,6+1
4.3 InChlKey
LVQDKIWDGQRHTE-VMGGCIAMSA-N
4.4 Canonical SMILES
C1CC1NC2=NC(=NC(=N2)N)N
4.5 lsomeric SMILES
C1CC1N[13C]2=N[13C](=N[13C](=N2)N)N
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病